Coronary In-stnent Restenosis Clinical Trial
Official title:
Observational Study of Treatment of Bioresorbable Vascular Scaffolds Restenosis
The treatment of patients with intra-stent restenosis (ISR) of Bioresorbable Vascular Scaffolds (Abbott Vascular) remains a challenge. This study will assess the incidence, predisposing factors, pathophysiology and prognosis of the patient in this setting.
Treatment of patients with ISR remains a challenge. Currently both drug-eluting stents (DES)
and drug-coated balloons (DCB) are considered as the strategies of choice in this setting.
However, existing data about ISR of BVS are scarce (isolated cases and retrospective series
with very few patients) on the incidence, predisposing factors, pathophysiology, treatment,
and long-term prognosis of these patients. In this sense, a prospective Spanish registry of
patients with ISR of DVB can obtain a very relevant clinical information that allows us to
advance in our knowledge about this phenomenon that helps to prevent it and to treat it in
the safest and most effective way possible.
Clinical events will be adjudicated by an independent Clinical Event Committee.
;